Titilope A Adeyemo - JoVE Visualize

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

The Lancet. Global Health|March 22, 2026

Intravenous ferric carboxymaltose versus oral ferrous sulphate for the treatment of moderate-to-severe postpartum anaemia in Nigerian women (IVON-PP): an open-label, randomised controlled trialBosede B Afolabi, Victoria O Adaramoye, Titilope A Adeyemo, et al.

Hemoglobin|January 20, 2026

Implementation of a Dedicated Hematopoietic Stem Cell Transplant Program for Sickle Cell Disease in Lagos, Nigeria: Challenges and OpportunitiesAdeseye M Akinsete, Olufunto Kalejaiye, Ugonna O Fakile, et al.

Human Molecular Genetics|February 10, 2024

The genetic dissection of fetal haemoglobin persistence in sickle cell disease in NigeriaOyesola O Ojewunmi, Titilope A Adeyemo, Ajoke I Oyetunji, et al.

Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

The Lancet. Global Health|March 22, 2026

Intravenous ferric carboxymaltose versus oral ferrous sulphate for the treatment of moderate-to-severe postpartum anaemia in Nigerian women (IVON-PP): an open-label, randomised controlled trialBosede B Afolabi, Victoria O Adaramoye, Titilope A Adeyemo, et al.

Hemoglobin|January 20, 2026

Implementation of a Dedicated Hematopoietic Stem Cell Transplant Program for Sickle Cell Disease in Lagos, Nigeria: Challenges and OpportunitiesAdeseye M Akinsete, Olufunto Kalejaiye, Ugonna O Fakile, et al.

Human Molecular Genetics|February 10, 2024

The genetic dissection of fetal haemoglobin persistence in sickle cell disease in NigeriaOyesola O Ojewunmi, Titilope A Adeyemo, Ajoke I Oyetunji, et al.

Pageof 4